T-cell Lymphoma

Oncology
3
Pipeline Programs
4
Companies
4
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Monoclonal Antibody
150%
Small Molecule
150%
+ 2 programs with unclassified modality

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Bristol Myers Squibb
1 program
1
EnasidenibPhase 2Small Molecule1 trial
Active Trials
NCT06756308Recruiting25Est. Dec 2027
Bayer
BayerLEVERKUSEN, Germany
1 program
1
CHOP and alemtuzumabPhase 1Monoclonal Antibody1 trial
Active Trials
NCT00161590Completed
Leadiant Biosciences
Leadiant BiosciencesMD - Rockville
1 program
1
PEG-L-asparaginasePhase 11 trial
Active Trials
NCT01878708Terminated2Est. Feb 2017
Takeda
TakedaTOKYO, Japan
1 program
T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas PatientsN/A1 trial
Active Trials
NCT03207789Unknown500Est. Dec 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Bristol Myers SquibbEnasidenib
Leadiant BiosciencesPEG-L-asparaginase
BayerCHOP and alemtuzumab
TakedaT-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients

Clinical Trials (4)

Total enrollment: 527 patients across 4 trials

NCT06756308Bristol Myers SquibbEnasidenib

A Study of Enasidenib in People With T-Cell Lymphoma

Start: Dec 2024Est. completion: Dec 202725 patients
Phase 2Recruiting
NCT01878708Leadiant BiosciencesPEG-L-asparaginase

A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma

Start: Jul 2013Est. completion: Feb 20172 patients
Phase 1Terminated
NCT00161590BayerCHOP and alemtuzumab

Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma

Start: Jul 2004
Phase 1Completed
NCT03207789TakedaT-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients

T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients

Start: Jan 2015Est. completion: Dec 2020500 patients
N/AUnknown

Related Jobs in Oncology

Cell Therapy Account Manager（北陸）

Gilead Sciences
Japan - Tokyo
Just now

Senior Director of Clinical Operations

Arvinas
Remote
1h ago

Specialist, Quality Assurance

Umoja Biopharma
Louisville, Colorado, United States
3h ago
$85K - $105K/yr

Senior Facilities Technician

Umoja Biopharma
Louisville, Colorado, United States
3h ago

Leo Cancer Care: Senior In-House Counsel/General Counsel

Leo Cancer Care
Middleton, Wisconsin
7h ago

Summer Intern - Computational Chemistry & Artificial Intelligence

Arvinas
Remote
8h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 527 patients
4 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)